ELITechGroup: Bruker Makes Two Year-End Acquisitions

In separate transactions, Bruker Corporation has entered into agreements to acquire in vitro diagnostics manufacturer ELITechGroup (ELITech), as well as cell imaging company Phasefocus. The acquisitions strengthen Bruker's position in molecular diagnostics and microscopy, respectively. According to a Dec. 26 regulatory filing, Bruker will acquire Elitec for a purchase price derived from an enterprise value of €870 million ($966.1 million), subject to certain adjustments. Terms of the Phasefocus acquisition were not disclosed. EliTech is active in the microbiology, clinical chemistry, and biomedical testing equipment markets. Phasefocus specializes in image processing in addition to optical microscopy. Bruker has...